Enliven Therapeutics, Inc (ELVN) Misses Q4 EPS by 2c Mar 3, 2026 04:36PM
Enliven Therapeutics adds Scott Garland to board, Andrew Phillips resigns Jan 7, 2026 09:03AM
Enliven Therapeutics names Rick Fair as new CEO Dec 11, 2025 09:01AM
Enliven Therapeutics, Inc (ELVN) Tops Q3 EPS by 18c Nov 12, 2025 04:43PM
BTIG Reiterates Buy Rating on Enliven Therapeutics (ELVN) Aug 14, 2025 05:33AM


Aug 13, 2025 06:05PM Enliven Therapeutics, Inc (ELVN) Tops Q2 EPS by 6c
Jul 2, 2025 06:38AM Enliven Therapeutics (ELVN) PT Raised to $48 at H.C. Wainwright
Jun 20, 2025 10:31AM TD Cowen Names Enliven Therapeutics (ELVN) Best Smidcap Idea
Jun 16, 2025 05:14AM Goldman Sachs Starts Enliven Therapeutics (ELVN) at Buy
Jun 13, 2025 09:31AM Enliven Therapeutics, Inc (ELVN) Prices 8.39M Share Offering at $19.66/sh
Jun 13, 2025 06:15AM Enliven Therapeutics, Inc (ELVN) Announces Proposed $200M Share Offering
Jun 13, 2025 06:03AM Enliven Therapeutics, Inc (ELVN) Announces Updated Positive Data from Phase 1 Clinical Trial of ELVN-001
May 30, 2025 06:37AM Enliven Therapeutics (ELVN) PT Raised to $41 at Mizuho
May 16, 2025 12:21PM Enliven Therapeutics (ELVN) PT Raised to $45 at BTIG, 'We increase our PoS for the ELVN-001 program and remove ELVN-002 from our model for HER2+ solid tumors'
May 15, 2025 06:48AM Enliven Therapeutics (ELVN) PT Raised to $40 at H.C. Wainwright
May 14, 2025 04:14PM Enliven Therapeutics, Inc (ELVN) Misses Q1 EPS by 7c
May 14, 2025 09:58AM Enliven Therapeutics, Inc (ELVN) announces updated positive data from Phase 1 ELVN-001 trial
Mar 13, 2025 04:12PM Enliven Therapeutics, Inc (ELVN) Tops Q4 EPS by 6c
Dec 13, 2024 06:02AM BTIG Starts Enliven Therapeutics (ELVN) at Buy
Dec 12, 2024 01:15PM Clear Street Starts Enliven Therapeutics (ELVN) at Buy, Top Pick
Nov 15, 2024 07:20AM Enliven Therapeutics (ELVN) PT Raised to $40 at Baird
Nov 13, 2024 09:04PM Enliven Therapeutics, Inc (ELVN) Tops Q3 EPS by 3c
Oct 30, 2024 04:13PM Jones Trading Starts Enliven Therapeutics (ELVN) at Buy
Oct 2, 2024 06:43AM H.C. Wainwright Reiterates Buy Rating on Enliven Therapeutics (ELVN)
Oct 1, 2024 07:13AM Mizuho Reiterates Outperform Rating on Enliven Therapeutics (ELVN)
Sep 30, 2024 08:38AM TD Cowen Reiterates Buy Rating on Enliven Therapeutics (ELVN)
Sep 23, 2024 11:00AM Mizuho Reiterates Outperform Rating on Enliven Therapeutics (ELVN)
Sep 9, 2024 06:32AM H.C. Wainwright Starts Enliven Therapeutics (ELVN) at Buy
Aug 19, 2024 06:42AM Enliven Therapeutics (ELVN) PT Raised to $39 at Mizuho
Aug 14, 2024 11:08AM TD Cowen Reiterates Buy Rating on Enliven Therapeutics (ELVN)
Jun 11, 2024 05:06AM Baird Starts Enliven Therapeutics (ELVN) at Outperform